Skip Navigation
  Search Menu
Find an Expert


Hyunseok Kang, M.D., M.P.H.

Photo of Dr. Hyunseok Kang, M.D., M.P.H.

Assistant Professor of Oncology


Languages: English, Japanese, Korean

Expertise: Head and Neck Cancers, Medical Oncology, Salivary Gland Tumors, Squameous Cell Carcinoma, Thyroid Cancer

Request an Appointment

I live in Maryland

Request an appointment through MyChart!

I live outside of Maryland

Request Appointment

I live outside of the United States

Request Appointment


Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Appointment Phone: 410-955-8893

401 N. Broadway
Baltimore, MD 21231 map
Phone: 410-502-3820
Fax: 410-955-8587


Dr. Kang is a clinician-scientist with a focus on novel therapeutics in head and neck cancer and a member of the Upper Aerodigestive Cancer Program.

Dr. Kang's research is primarily focused on design and conduct of clinical trials in head and neck cancers including head and neck squamous cell carcinomas, salivary gland cancers and other rare cancers of head and neck. He is also involved in translational research of novel treatment approaches such as immunotherapy and targeted therapy. In addition, he serves as an attending on the inpatient solid tumor service and supervise oncology fellows in clinic. more


  • Assistant Professor of Oncology
  • Assistant Professor of Otolaryngology - Head and Neck Surgery



  • MD, Yonsei University College of Medicine (2002)


  • Mount Sinai St. Luke's - Roosevelt Hospitals / Internal Medicine (2010)


  • Emory University School of Medicine (2013)

Board Certifications

  • American Board of Internal Medicine / Internal Medicine (2010)
  • American Board of Internal Medicine / Medical Oncology (2013)

Research & Publications

Research Summary

Dr. Kang is interested in developing novel therapeutics in treatment of head and neck squamous cell carcinomas and salivary gland cancers. Dr.Kang's goal is to provide better way to understand and manage head and neck cancers through the research.

Clinical Trial Keywords

Head and Neck Cancer, Salivary Gland Cancer, Immunotherapy, Drug Development

Selected Publications

View all on Pubmed

Kang H, Tan M, Bishop JA, Jones S, Sausen M, Ha PK, Agrawal N. Whole-exome sequencing of salivary gland mucoepidermoid carcinoma. Clin Cancer Res 2017;23(1):283-288

Kang H, Kiess AP and Chung CH. Emerging biomarkers in head and neck cancer in the era of genomics. Nat Rev Clin Oncol 2015;12(1):11-26.

Dalton WB, Forde PM, Kang H, Connolly RM, Stearns V, Gocke CD, Eshleman JR, Axilbund J, Petry D, Geohegan C, Wolff AC, Loeb DM, Pratilas CA, Meyer CF, Christenson ES, Slater SA, Ensminger J, Parsons HA, Park BH, Lauring J. Personalized medicine in the oncology clinic: Implementation and outcomes of the Johns Hopkins molecular tumor board. JCO Precision Oncology 2017; doi:10.1200/PO.16.00046

Bauml J, Seiwert TY, Pfister DG, Worden F, Liu SV, Gilbert J, Saba NF, Weiss J, Wirth L, Sukari A, Kang H, Gibson MK, Massarelli E, Powell S, Meister A, Shu X, Cheng J, Haddad R. Pembrolizumab for platinum- and cetuximab-refractory head and neck cancer: Results from a single-arm, phase II study. J Clin Oncol 2017;35(14):1542-1549

Anagnostou V, Smith KN, Forde PM, Niknafs N, Bhattacharya R, White J, Zhang T, Adleff V, Phallen J, Wali N, Hruban C, Guthrie VB, Rogers K, Naidoo J, Kang H, Sharfman WH, Georgiades C, Verde F, Illei P, Li QK, Gabrielson E, Brock MV, Zahnow CA, Baylin SB, Scharpf R, Brahmer JR, Karchin R, Pardoll DM, Velculescu VE. Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer. Cancer Discov 2017;7(3):264-276

Activities & Honors


  • American Association for Cancer Research, 2011


  • American College of Physicians, 2015

    Fellow (FACP)

  • American Society of Clinical Oncology
  • Society for Immunotherapy of Cancer


Professional Activities

  • Co-director for Oncology Grand Rounds, Educational committee, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 2015
Is this you? Edit Profile